IP Library Granted Patent US 10,988,509
Granted Patent B2
US 10,988,509 · App. 15/572,126 · Granted Apr 27, 2021

Method of culturing

Inventors: Clara Belzer (Wageningen, NL); Willem Meindert De Vos (Ede, NL)
Assignee: WAGENINGEN UNIVERSITEIT
C07K14/195A61P3/06A61P3/08C12N1/20A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,988,509
App. No.
15/572,126
Granted
Apr 27, 2021
Kind
B2
Abstract

A method for cost-effectively and efficiently culturing Akkermansia muciniphilais is disclosed. High biomass yields can be obtained on chemically defined media. This allows for large scale production of A. muciniphila suitable for use in humans, such as for pharmaceutical or food applications. The A. muciniphila can be produced free of animal-derived products, thereby allowing a broad-range of applications.

Claims (15)

1. A method of culturing bacteria of the species Akkermansia muciniphila , said method comprising:

inoculating a composition with bacteria of the species Akkermansia muciniphila , said composition comprising glucose, a nitrogen-containing derivative of a monosaccharide, threonine, and an amino acid source,

said nitrogen-containing derivative of a monosaccharide selected from the group consisting of N-acteyl-glucosamine (Glc-NAc) and N-acteyl-galactosamine (Gal-NAc).

2. The method according to claim 1 , wherein the nitrogen-containing derivative of a monosaccharide is Glc-NAc.

3. The method according to claim 1 , wherein the nitrogen-containing derivative of a monosaccharide is Glc-NAc present in an amount ranging from about 0.001 mM to about 1 M.

4. The method according to claim 1 , wherein the glucose is present in an amount ranging from about 0.001 M to about 1 M.

5. The method according to claim 1 , wherein the threonine is present in an amount ranging from about 0.01 mM to about 100 mM.

6. The method according to claim 1 , wherein the amino acid source is selected from a plant-based amino acid source, a microbial-based amino acid source, or a combination of alanine, glutamate, proline and serine.

7. The method according to claim 1 , wherein the amino acid source is a plant protein hydrolysate.

8. The method according to claim 1 , wherein the amino acid source is a plant protein hydrolysate present in an amount ranging from about 0.01 g/l to about 1 kg/l.

9. The method according to claim 1 , wherein the amino acid source is a plant protein hydrolysate present in an amount ranging from about 0.05 to about 500 g/l.

10. The method according to claim 1 , wherein the amino acid source is a plant protein hydrolysate present in an amount ranging from about 0.1 to about 250 g/l.

11. The method according to claim 1 , wherein the amino acid source is a plant protein hydrolysate present in an amount ranging from about 0.5 to about 150 g/l.

12. The method according to claim 1 , wherein the amino acid source is a plant protein hydrolysate present in an amount ranging from about 1 to about 100 g/l.

13. The method according to claim 1 , wherein the amino acid source is a plant protein hydrolysate present in an amount ranging from about 2 to about 80 g/l.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2025
From: WAGENINGEN UNIVERSITEIT; SOPARTEC SA; UNIVERSITÉ CATHOLIQUE DE LOUVAIN
To: COMPAGNIE GERVAIS DANONE
Reel/Frame 071836/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2018
From: BELZER, CLARA; DE VOS, WILLEM MEINDERT
To: WAGENINGEN UNIVERSITEIT
Reel/Frame 044751/0502 →
Priority Claims (1)
EP 15166598 · May 6, 2015 · regional
Continuity (1)
Related Publication 20180094233A1 · Apr 5, 2018
Cited By (1)
US 12,351,794